The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease

American Journal of Gastroenterology

Volumn 107, Issue 6, 2012, Pages 941-949

  Henderson, Paul ^a,b   Casey, Aoife ^b   Lawrence, Sally J ^b   Kennedy, Nicholas A ^a   Kingstone, Kathleen ^c   Rogers, Pam ^b   Gillett, Peter M ^b   Wilson, David C ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALGRANULIN; FECAL CALPROTECTIN; HEMOGLOBIN; UNCLASSIFIED DRUG;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84861882865     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.33     Document Type: Article

References (35)

1. Henderson P, Hansen R, Cameron FL et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2011. Published online first:17 June 2011. doi:10.1002/ibd.21797.
2. Benchimol EI, Fortinsky KJ, Gozdyra P et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423-39.
3. Beniwal P, Harrell L. Th e status of diagnostic markers for inflammatory bowel disease. Curr Gastroenterol Rep 2010;12:479-84.
4. Diamanti A, Panetta F, Basso MS et al. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay. Inflamm Bowel Dis 2010;16:1926-30.
5. Schoepfer AM, Trummler M, Seeholzer P et al. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis 2008;14:32-9. (Pubitemid 351196866)
6. Roseth AG, Fagerhol MK, Aadland E et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.
7. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369.
8. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 (Suppl 170):2-6. (Pubitemid 20015811)
9. IBD working group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005;41:1-7.
10. Van Limbergen J, Russell RK, Drummond HE et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22.
11. Stevenson M. epiR: Functions for analysing epidemiological data. (R package version 0.9-33). Available from: http://cran.r-project.org/web/packages/ epiR/index.html (accessed: 2 November 2011).
12. Robin X, Turck N, Hainard A et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
13. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
14. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
15. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43. (Pubitemid 13033817)
16. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl A):5-36.
17. Levine A, Griffiths A, Markowitz J et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21.
18. Fagerhol MK, Dale I, Anderson T. Release and quantitation of a leucocyte derived protein (L1). Scand J Haematol 1980;24:393-8. (Pubitemid 10080486)
19. Lusitani D, Malawista SE, Montgomery RR. Calprotectin, an abundant cytosolic protein from human polymorphonuclear leukocytes, inhibits the growth of Borrelia burgdorferi. Infect Immun 2003;71:4711-6. (Pubitemid 36919939)
20. Murthy AR, Lehrer RI, Harwig SS et al. In vitro candidastatic properties of the human neutrophil calprotectin complex. J Immunol 1993;151:6291-301. (Pubitemid 23340375)
21. Loomans HJ, Hahn BL, Li QQ et al. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin. J Infect Dis 1998;177:812-4. (Pubitemid 28099907)
22. Bunn SK, Bisset WM, Main MJ et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;33:14-22. (Pubitemid 32706118)
23. Bremner A, Roked S, Robinson R et al. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr 2005;94:1855-8. (Pubitemid 43155608)
24. Walkiewicz D, Werlin SL, Fish D et al. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2008;14:669-73. (Pubitemid 351742984)
25. Fagerberg UL, Loof L, Myrdal U et al. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005;40:450-5. (Pubitemid 40489572)
26. Canani RB, de Horatio LT, Terrin G et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006;42:9-15. (Pubitemid 43061003)
27. Bonnín Tomàs A, Vila Vidal M, Rosell Camps A. Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease. Rev Esp Enferm Dig 2007;99:689-93. (Pubitemid 351416315)
28. Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis 2008;14:359-66. (Pubitemid 351441325)
29. Perminow G, Brackmann S, Lyckander LG et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease. Scand J Gastroenterol 2009;44:446-56.
30. Fagerberg UL, Loof L, Lindholm J et al. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;45:414-20. (Pubitemid 350307158)
31. Russell RK, Ip B, Aldhous MC et al. Anti- Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease. J Pediatr Gastroenterol Nutr 2009;48:161-7.
32. Lehrke M, Konrad A, Schachinger V et al. CXCL16 is a surrogate marker of inflammatory bowel disease. Scand J Gastroenterol 2008;43:283-8. (Pubitemid 351238351)
33. Mack DR, Langton C, Markowitz J et al. Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics 2007;119:1113-9. (Pubitemid 46871266)
34. Tsampalieros A, Griffiths AM, Barrowman N et al. Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease. J Pediatr 2011;159:340-2.
35. Quail MA, Russell RK, Van Limbergen JE et al. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease. Inflamm Bowel Dis 2009;15:756-9.